Key Takeaways
- Singapore Budget 2026 committed S$37 billion to the RIE2030 (Research, Innovation and Enterprise 2030) plan
- An additional S$1 billion under Startup SG Equity expands support from early-stage to growth-stage companies
- The Budget speech pointed to emerging areas such as quantum technology and decarbonisation solutions, alongside clusters such as aerospace and biomedical sciences
- The Enterprise Innovation Scheme's 400% tax deductions will cover qualifying AI expenditure for YA2027 and YA2028, capped at S$50,000 per Year of Assessment
- National AI Missions will focus on four sectors: advanced manufacturing, connectivity, finance, and healthcare
The Facts
Singapore's Budget 2026 announced one of the most significant research and innovation investment commitments in the city-state's history: S$37 billion under the Research, Innovation and Enterprise 2030 (RIE2030) plan. The plan covers five years of investments across Singapore's public research agencies, universities, and the ecosystem programmes that support commercialisation and enterprise adoption of research outcomes.
The Budget speech said research investment must be directed at areas where Singapore has clear strengths. It pointed to potential in emerging areas such as decarbonisation solutions and quantum technology, and tied research and innovation to growth clusters including aerospace and biomedical sciences. The speech put the commitment at around 1% of GDP each year.
The Startup SG Equity expansion — adding S$1 billion to extend government co-investment support from early-stage startups to growth-stage companies — addresses a long-standing gap in Singapore's startup ecosystem. Early-stage capital has been accessible through various government schemes; growth-stage capital (Series B-D) has been constrained by the smaller pool of institutional venture capital with ASEAN focus.
Technical Deep-Dive
The National AI Missions represent the most significant policy commitment for Singapore's AI community. Budget 2026 said the missions will focus on four sectors — advanced manufacturing, connectivity, finance, and healthcare — providing directional investment priorities that create both research funding opportunities and procurement signals for AI companies developing products in these domains.
The healthcare AI mission aligns with the MOH's AIHGle 2.0 guidelines and the AimSG platform (the national portal for hospital access to imaging AI). Startups building healthcare AI products in Singapore benefit from access to Singapore's TRUST and HEALIX data infrastructure — providing clinical datasets that are unavailable in most other markets.
The Enterprise Innovation Scheme already provides 400% tax deductions on qualifying expenditure in activities such as R&D, innovation, and capability development. Budget 2026 adds AI expenditure as a qualifying activity for YA2027 and YA2028, capped at S$50,000 per Year of Assessment. For a company spending S$50,000 on qualifying AI expenditure, the 400% deduction generates S$200,000 in tax-deductible expenditure — reducing taxable income substantially for profitable enterprises.
The ASEAN Perspective
Singapore's RIE2030 investment positions the city-state as the research commercialisation hub for ASEAN — conducting research that addresses regional challenges, developing technologies that can be deployed across the region, and providing the regulatory sandboxes that validate product approaches before ASEAN-wide deployment.
For ASEAN startups, Singapore's enhanced growth-stage funding under Startup SG Equity reduces the Series B gap that has historically required ASEAN startups to seek US or European venture capital at the growth stage. Singapore co-investment in growth-stage rounds crowds in private capital and increases the pool of growth-stage funding available regionally.
For international technology companies evaluating ASEAN market entry, Singapore's research infrastructure — A*STAR, NUS, NTU, and industry research labs — provides collaboration opportunities that are unique in the region. The combination of world-class research institutions, IP-friendly regulatory environment, and government co-investment programmes creates an ecosystem for technology commercialisation that most ASEAN markets cannot replicate.
RECATOOLS Verdict
Singapore's S$37 billion RIE2030 commitment is scale-appropriate for a city-state with limited natural resources that has historically competed on human capital and institutional quality. Sustaining that competitive position as AI fundamentally changes the economics of knowledge work requires exactly this level of deliberate investment.
For ASEAN tech entrepreneurs, the RIE2030 framework provides both direct funding opportunities and the policy framework that signals where Singapore's enterprise market will grow over the next five years.
Frequently Asked Questions
The Research, Innovation and Enterprise 2030 plan — a S$37 billion five-year investment in research, innovation infrastructure, and commercialisation ecosystems, amounting to around 1% of GDP each year.
Budget 2026 said the National AI Missions will drive AI-led transformation in four sectors: advanced manufacturing, connectivity, finance, and healthcare.
A tax deduction scheme offering 400% deductions on qualifying expenditure such as R&D and innovation. For YA2027 and YA2028 it also covers qualifying AI expenditure, capped at S$50,000 per Year of Assessment.
A government co-investment programme for Singapore startups; the S$1 billion Budget 2026 expansion extends coverage from early-stage to growth-stage companies.
Singapore's growth-stage funding expansion reduces the Series B funding gap and crowds in private capital — improving access to growth financing for ASEAN startups based in Singapore.
Correction, 18 October 2026: An earlier version misstated the four sectors named for Singapore's national missions in Budget 2026, and described four fixed research domains for RIE2030 that the Budget did not set out. The description of the Enterprise Innovation Scheme has also been clarified.